ARCHIVES

Phase III Trial Would Give Clearer Picture of C225 Role

This article is from The Cancer Letter archive.

Vol. 28 No. | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Trimodality Therapy Improves Survival In Early Disease

January 27, 2006

Sponsors Withdraw Indications for Iressa, Celebrex

February 11, 2011

OCC Has Answers Ready Or Most Questions Asked

March 21, 1980

Katterhagen, Nelson Reelected ACCC Leaders

February 4, 1977

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

CPT Code Changes Confuse Oncologists, Appear To Bloc Some Chemotherapy Payments

April 6, 1990